Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2015-04-14 Capital/Financing Update
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 14, 2015. It announces the approval of a new share repurchase program by the company's Board of Directors, detailing the amount authorized and terms of the repurchase. The document also includes updated risk factors incorporated by reference but does not contain full financial statements or detailed financial analysis. The primary content is an announcement of a capital activity (share repurchase program). According to the filing definitions, updates on company fundraising, financing activities, or capital structure changes fall under Capital/Financing Update (CAP). The document is not a full financial report, earnings release, or regulatory filing of another type. Therefore, the correct classification is CAP with high confidence.
2015-04-14 English
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 14, 2015, for DaVita HealthCare Partners Inc. It announces two press releases: one about an offering of $1.25 billion senior notes and another about a cash tender offer for senior notes due 2020. The content focuses on financing activities, specifically debt issuance and tender offers. The document length is 3231 characters, which is relatively short and mainly contains announcements and press releases rather than detailed financial statements or analysis. Therefore, this filing is best classified as a Capital/Financing Update (CAP) since it relates to fundraising and capital structure changes through senior notes offering and tender offer announcements.
2015-04-14 English
FWP Filing
Capital/Financing Update Classification · 100% confidence The document is a Final Term Sheet filed pursuant to Rule 433, related to a $1.5 billion senior notes offering by DaVita HealthCare Partners Inc. It includes detailed terms of the debt issuance such as coupon rate, maturity, redemption options, use of proceeds, and underwriting details. This is a capital markets document focused on financing activities, specifically a debt offering. It is not a full financial report, earnings release, or management discussion. It is not an announcement of a report publication but the actual term sheet for a financing transaction. Therefore, it fits best under the category for Capital/Financing Update (CAP). The document length and content confirm it is substantive and not a brief announcement or certification.
2015-04-14 English
S-3ASR Filing
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities offerings under the Securities Act of 1933. It includes a prospectus for debt securities and guarantees, describing the terms and conditions of potential securities offerings. This is a regulatory filing related to capital raising activities but is not a financial report, earnings release, or management discussion. It is not an announcement of voting results, board changes, or legal proceedings. The document is lengthy (15,000 characters) and contains detailed registration information, but it is not a report or presentation. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2015-04-14 English
4 Filing
Director's Dealing
2015-04-08 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on a Regulation FD Disclosure regarding the Centers for Medicare and Medicaid Services (CMS) final 2016 Medicare Advantage benchmark payment rates and their estimated impact on the company's operating income. It includes forward-looking statements and risk factors but does not contain comprehensive financial statements or detailed financial analysis. The document is 8473 characters long, which is relatively short and primarily serves as an announcement of a regulatory update and its expected impact rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories like earnings releases or annual reports.
2015-04-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.